First drug to slow progression of Alzheimer's disease approved in US
The US Food and Drug Administration has fully approved a drug that slows the progression of Alzheimer's disease for the first time.
The FDA has granted full regulatory approval to Leqembi - a drug by Japanese manufacturers Eisai and US drugmakers Biogen. Up to now, other approved drugs targeted only the symptoms of the progressive disease, but Leqembi focuses on a protein in the brain, beta-amyloid, believed to be one of the main causes of Alzheimer's.Leqembi will cost $26,000 a year, although Medicare - theImage:When researchers measured the drug's effectiveness in a clinical trial, Leqembi slowed down the progression of the illness of those with mild cognitive impairment or early-stage disease by 27% over an 18-month period.
However, some medical professionals have criticised it for contributing to brain swelling and haemorrhages - there were also three deaths linked to the drug in the trials.
Danmark Seneste Nyt, Danmark Overskrifter
Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.
Fiona Phillips describes first Alzheimer's symptom she spotted before diagnosisThe former ITV presenter and her husband say it 'all started' in one moment as she shared her heartbreaking diagnosis aged just 62.
Læs mere »
The 5 early signs of Alzheimer's as Fiona Philips, 62, shares first symptomsTV host Fiona Philips has revealed she’s been diagnosed with Alzheimer’s disease at 62. The former GMTV presenter said she was convinced her brain fog and anxiety was due to the menopau…
Læs mere »
US regulators approve first drug to slow progression of Alzheimer’s\n\t\t\tKeep abreast of significant corporate, financial and political developments around the world.\n\t\t\tStay informed and spot emerging risks and opportunities with independent global reporting, expert\n\t\t\tcommentary and analysis you can trust.\n\t\t
Læs mere »
The First Fully Approved Alzheimer's Drug Won’t Be Easy To GetThe FDA has granted full approval for lecanemab, or Leqembi, to treat Alzheimer’s in people in the early, mild stages of the neurodegenerative condition
Læs mere »
Susanna Reid's emotional tribute to Fiona Phillips after Alzheimer's diagnosisFormer GMTV presenter Fiona Phillips has announced she has been diagnosed with Alzheimer's
Læs mere »
Warning signs of Alzheimer’s as Fiona Phillips reveals heartbreaking diagnosisThe warning signs of Alzheimer’s Disease as Fiona Phillips reveals heartbreaking diagnosis aged just 62
Læs mere »